![]() |
市場調查報告書
商品編碼
1954605
全球臨床圍產期軟體市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Clinical Perinatal Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球臨床圍產期軟體市場規模為3.7573億美元,預計將從2026年的4.062億美元成長到2034年的9.893億美元,預測期內年複合成長率高達11.77%。北美將在2025年以41.32%的市場佔有率引領市場,這主要得益於數位醫療的日益普及和人們對孕產婦健康的日益關注。
市場概覽
臨床圍產期軟體是指用於孕產婦、胎兒和新生兒照護的專用數位平台。這些系統透過即時監測、臨床決策支援以及與電子健康記錄(EHR)的整合,為醫療保健專業人員提供妊娠管理、分娩和新生兒護理方面的支援。人們越來越重視降低與分娩相關的風險、改善孕產婦結局以及醫院系統的數位化,這些因素都顯著推動了市場成長。
General Electric Company、Koninklijke Philips N.V.、PeriGen, Inc.、Clinical Computer Systems, Inc.等領導企業正透過創新產品和全球部署策略鞏固其市場地位。
市場驅動因素
日益嚴重的孕產婦和新生兒健康風險
全球孕產婦和新生兒併發症負擔日益加重是市場成長的主要驅動因素。子癇前症、產後出血、產程停滯、產程缺氧和早產相關併發症等情況需要持續監測和早期介入。
根據世界衛生組織2025年 4月發布的報告,2023年約有 26萬名婦女死於妊娠和分娩相關原因,其中約 90%的死亡病例發生在低收入和中等收入國家。臨床圍產期軟體透過實現早期檢測、即時胎兒監測和改善臨床決策,在降低死亡率方面發揮著非常重要的作用。
市場限制因子
新興經濟體採用率的延遲限制了整體市場擴張。基礎設施差異、軟體實施成本高昂、訓練有素的人員短缺以及對捐助方資助計畫的依賴阻礙了廣泛部署。例如,尚比亞的電子圍產期記錄系統(ZEPRS)是在國際資助機構的支持下實施的,這凸顯了其對外部資金的高度依賴。
IT 基礎設施和整合的高昂初始成本進一步延緩了小型醫院和專科診所採用該系統。2024年,英國衛生和社會事務部和英格蘭國民醫療服務體系(NHS England)每年投資 2.25億美元用於加強產科和新生兒護理,這表明需要投入大量資金。
市場機會
與遠距醫療和遠距監測的整合
結合線上和線下諮詢的混合式產前護理模式逐步普及,這帶來了巨大的商機。新冠疫情期間,遠距醫療的普及率激增。根據美國國家生物技術資訊中心(NCBI)於2023年 6月發布的一項研究,截至2020年 11月,17.3%的參與者接受遠距產前護理,與2020年之前的1%相比,這一比例顯著成長。
基於雲端的SaaS 平台、行動應用程式和連網監測設備擴大孕產婦保健服務的覆蓋範圍,同時為醫療服務提供者創造基於訂閱的收入模式。
市場趨勢
遷移到雲端和 SaaS 應用程式
由於成本效益、可擴展性和遠端存取性,醫院加速向雲端系統遷移。儘管本地部署系統仍佔據主導地位,但雲端解決方案迅速發展,尤其是在高收入國家。
依類型
受無縫資料整合和工作流程效率的需求驅動,整合系統在2026年佔據市場主導地位,市場佔有率達69.18%。整合系統消除了資料孤島,有助於提高臨床決策的準確性。
依部署方式
由於醫院優先考慮資料安全和合規性,本地部署系統在2026年佔據了73.25%的市場佔有率。然而,預計到2034年,基於雲端的細分市場將以 13.93%的年複合成長率成長。
依應用領域劃分
胎兒監護領域佔據領先地位,2025年市場佔有率為 37.4%,2026年市場佔有率為 36.74%,這主要歸功於其在檢測異常心率模式和預防新生兒併發症方面的臨床重要性。預計在預測期內,孕產婦健康管理產業將以 12.52%的年複合成長率成長。
依最終使用者劃分
醫院和診所作為管理高風險妊娠和新生兒重症監護病例的機構,在2025年佔據 69.7%的市場佔有率,在2026年佔據 69.49%的市場佔有率。預計到2034年,專科診所將以 12.44%的年複合成長率成長。
2025年,北美市場規模將達到 1.5525億美元,到2026年將成長至 1.6817億美元,繼續保持其在該地區的領先地位。預計到2026年,光是美國市場規模就將達到1.5442億美元,主要得益於孕產婦死亡率的上升(2022年為每10萬活產22.3例死亡)。
2025年,歐洲市場規模達到9,280萬美元,年複合成長率為9.96%。德國預計到2026年將達到2,394萬美元,英國和法國也呈現穩定成長。
亞太地區市場規模在2025年達到8,500萬美元,其中中國和印度預計在2026年將分別達到2,376萬美元和1,838萬美元。
拉丁美洲地區在2025年達到2,440萬美元,而中東和非洲GCC地區在2025年達到760萬美元。
The global clinical perinatal software market was valued at USD 375.73 million in 2025 and is projected to grow from USD 406.2 million in 2026 to USD 989.3 million by 2034, registering a strong CAGR of 11.77% during the forecast period. North America dominated the market in 2025 with a 41.32% share, driven by high digital health adoption and rising maternal health concerns.
Market Overview
Clinical perinatal software refers to specialized digital platforms used in maternal-fetal and neonatal care. These systems support healthcare providers in managing pregnancy, labor & delivery, and newborn care through real-time monitoring, clinical decision support, and integration with electronic health records (EHRs). The growing emphasis on reducing birth-related risks, improving maternal outcomes, and digitizing hospital systems is significantly contributing to market growth.
Leading players such as General Electric Company, Koninklijke Philips N.V., PeriGen, Inc., and Clinical Computer Systems, Inc. are strengthening their positions through innovative product launches and global expansion strategies.
Market Drivers
Rising Maternal & Neonatal Health Burden
The increasing global burden of maternal and neonatal complications is a primary driver of market growth. Conditions such as preeclampsia, hemorrhage, obstructed labor, intrapartum hypoxia, and prematurity-related complications require continuous monitoring and early intervention.
According to a WHO report published in April 2025, approximately 260,000 women died from pregnancy and childbirth-related causes in 2023, with nearly 90% occurring in low- and middle-income countries. Clinical perinatal software plays a crucial role in reducing mortality by enabling early detection, real-time fetal monitoring, and improved clinical decision-making.
Market Restraints
Limited adoption in emerging economies restricts overall market expansion. Infrastructure gaps, high software implementation costs, lack of trained personnel, and reliance on donor-funded programs hinder widespread deployment. For instance, Zambia's Electronic Perinatal Record System (ZEPRS) was implemented with support from global funding organizations, highlighting dependency on external financial assistance.
High upfront costs for IT infrastructure and integration further slow adoption among smaller hospitals and specialty clinics. In 2024, the Department of Health and Social Care and NHS England invested USD 225 million annually to enhance maternity and neonatal care, demonstrating the significant financial commitment required.
Market Opportunities
Integration with Telehealth & Remote Monitoring
The growing shift toward hybrid prenatal care models combining digital consultations with in-person visits presents a lucrative opportunity. Telehealth adoption surged during the COVID-19 pandemic. A study published by NCBI in June 2023 revealed that 17.3% of participants had telehealth prenatal visits in November 2020, compared to just 1% before 2020.
Cloud-based SaaS platforms, mobile apps, and connected monitoring devices are expanding access to maternal care while creating subscription-based revenue models for providers.
Market Trends
Shift Toward Cloud & SaaS Deployment
Hospitals are increasingly migrating toward cloud-based systems due to cost efficiency, scalability, and remote accessibility. Although on-premise systems currently dominate, cloud-based solutions are gaining traction, especially in high-income countries.
By Type
The integrated segment led the market with a 69.18% share in 2026, driven by demand for seamless data integration and improved workflow efficiency. Integrated systems reduce data silos and enhance clinical decision-making.
By Deployment
The on-premise segment accounted for 73.25% share in 2026, as hospitals prioritize data security and regulatory compliance. However, the cloud-based segment is projected to grow at a CAGR of 13.93% through 2034.
By Application
The fetal monitoring segment dominated with 37.4% share in 2025 and 36.74% in 2026, due to its clinical importance in detecting abnormal heart rate patterns and preventing neonatal complications. The maternal health management segment is projected to grow at 12.52% CAGR during the forecast period.
By End-User
Hospitals & clinics held 69.7% share in 2025 and 69.49% in 2026, as these settings manage high-risk pregnancies and neonatal intensive care cases. Specialty clinics are expected to grow at a CAGR of 12.44% through 2034.
In 2025, North America generated USD 155.25 million, increasing to USD 168.17 million in 2026, maintaining regional leadership. The U.S. market alone is estimated at USD 154.42 million in 2026, supported by rising maternal mortality rates (22.3 deaths per 100,000 live births in 2022).
Europe is projected to reach USD 92.8 million in 2025, growing at a CAGR of 9.96%. Germany is expected to reach USD 23.94 million in 2026, while the U.K. and France show steady growth.
Asia Pacific is valued at USD 85.0 million in 2025, with China and India reaching USD 23.76 million and USD 18.38 million in 2026, respectively.
Latin America recorded USD 24.4 million in 2025, while GCC in the Middle East & Africa reached USD 7.6 million in 2025.
Competitive Landscape
The market is moderately fragmented with dominant players including:
Recent developments include OBIX's partnership with Dubai Health (January 2025) and BrightHeart's FDA clearance for AI fetal heart ultrasound software (November 2024).
Conclusion
The global clinical perinatal software market is poised for strong expansion, growing from USD 375.73 million in 2025 to USD 989.3 million by 2034. Rising maternal health challenges, increasing digital health adoption, and growing integration of telehealth and AI-driven monitoring systems are key growth drivers. While high implementation costs and limited adoption in emerging economies present challenges, expanding cloud-based solutions and government investments are expected to sustain long-term growth across global healthcare systems.
Segmentation By Type
By Deployment
By Application
By End User
By Geography